Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Annals of Internal Medicine
|
February 18, 2009
Can the SMART study data be used to assess risk factors for renal disease?
Samir K Gupta
The AIDS Reader
|
August 1, 2009
Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Samir K Gupta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2005
Tenofovir and changes in renal function
Samir K Gupta
The Lancet. Infectious Diseases
|
December 3, 2014
Antiretroviral treatment initiation
Samir K Gupta
AIDS Patient Care and Stds
|
February 12, 2008
Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system
Samir K Gupta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 31, 2002
Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy
Samir K Gupta, Michael P Dubé
European Journal of Clinical Pharmacology
|
November 1, 2011
Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Drug Discoveries & Therapeutics
|
May 13, 2014
Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Drug Discoveries & Therapeutics
|
September 28, 2013
Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Kidney International
|
September 17, 2008
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell
Kara K Wools-Kaloustian, Samir K Gupta
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Annals of Internal Medicine
|
February 18, 2009
Can the SMART study data be used to assess risk factors for renal disease?
Samir K Gupta
The AIDS Reader
|
August 1, 2009
Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
Samir K Gupta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2005
Tenofovir and changes in renal function
Samir K Gupta
The Lancet. Infectious Diseases
|
December 3, 2014
Antiretroviral treatment initiation
Samir K Gupta
AIDS Patient Care and Stds
|
February 12, 2008
Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system
Samir K Gupta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 31, 2002
Exogenous cushing syndrome mimicking human immunodeficiency virus lipodystrophy
Samir K Gupta, Michael P Dubé
European Journal of Clinical Pharmacology
|
November 1, 2011
Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Drug Discoveries & Therapeutics
|
May 13, 2014
Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Drug Discoveries & Therapeutics
|
September 28, 2013
Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment
Samir K Gupta, Bhavna Kantesaria, Paul Glue
Kidney International
|
September 17, 2008
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell
Kara K Wools-Kaloustian, Samir K Gupta
Page
of 12